A Real Picture of Edgewise Therapeutics Inc (EWTX) Stock: The Fundamentals

Piper Sandler raised the price target for the Edgewise Therapeutics Inc (NASDAQ:EWTX) stock to “an Overweight”. The rating was released on March 07, 2024, according to finviz. The research report from Goldman has downgraded the stock from Neutral to Sell, with a price target set at $5. The stock was initiated by RBC Capital Mkts, […]